Literature DB >> 27384660

Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.

Jisu Li1, Li Zong2, Camille Sureau3, Luke Barker4, Jack R Wands4, Shuping Tong2.   

Abstract

UNLABELLED: Cell culture (cc)-derived hepatitis B virus (HBV) can infect differentiated HepaRG cells, but efficient infection requires addition of polyethylene glycol (PEG) during inoculation. Identification of sodium taurocholate cotransporting polypeptide (NTCP) as an HBV receptor enabled ccHBV infection of NTCP reconstituted HepG2 cells, although very little hepatitis B surface antigen (HBsAg) is produced. We found infection by patient serum-derived HBV (sHBV), which required purification of viral particles through ultracentrifugation or PEG precipitation, was PEG independent and much more efficient in HepaRG cells than in HepG2/NTCP cells. In contrast to hepatitis B e antigen (HBeAg), HBsAg was not a reliable marker of productive sHBV infection at early time points. A low HBsAg/HBeAg ratio by ccHBV-infected HepG2/NTCP cells was attributable to dimethyl sulfoxide (DMSO) in culture medium, NTCP overexpression, and HBV genotype D. HepG2/NTCP cells released more viral antigens than HepG2 cells after HBV genome delivery by adeno-associated virus, and stable expression of NTCP in a ccHBV producing cell line increased viral mRNAs, proteins, replicative DNA, and covalently closed circular DNA. NTCP protein expression in HepG2/NTCP cells, despite being driven by the cytomegalovirus promoter, was markedly increased by DMSO treatment. This at least partly explains ability of DMSO to promote ccHBV infection in such cell lines. In conclusion, NTCP appeared inefficient to mediate infection by serum-derived HBV. It could promote HBV RNA transcription while inhibiting HBsAg secretion. Efficient PEG-independent sHBV infection of HepaRG cells permits comparative studies of diverse clinical HBV isolates and will help identify additional factors on virion surface promoting attachment to hepatocytes. IMPORTANCE: Currently in vitro infection with hepatitis B virus (HBV) depends on cell culture-derived HBV inoculated in the presence of polyethylene glycol. We found patient serum-derived HBV could efficiently infect differentiated HepaRG cells independent of polyethylene glycol, which represents a more physiological infection system. Serum-derived HBV has poor infectivity in HepG2 cells reconstituted with sodium taurocholate cotransporting polypeptide (NTCP), the currently accepted HBV receptor. Moreover, HepG2/NTCP cells secreted very little hepatitis B surface antigen after infection with cell culture-derived HBV, which was attributed to NTCP overexpression, genotype D virus, and dimethyl sulfoxide added to culture medium. NTCP could promote HBV RNA transcription, protein expression, and DNA replication in HepG2 cells stably transfected with HBV DNA, while dimethyl sulfoxide could increase NTCP protein level despite transcriptional control by a cytomegalovirus promoter. Therefore, this study revealed several unusual features of NTCP as an HBV receptor and established conditions for efficient serum virus infection in vitro.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27384660      PMCID: PMC5008102          DOI: 10.1128/JVI.01153-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Hepatitis B and D viral receptors.

Authors:  Jisu Li; Jack Wands
Journal:  Hepatology       Date:  2015-11-17       Impact factor: 17.425

Review 2.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

Review 3.  Overview of hepatitis B viral replication and genetic variability.

Authors:  Shuping Tong; Peter Revill
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

4.  Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.

Authors:  Matthieu Blanchet; Camille Sureau; Patrick Labonté
Journal:  Antiviral Res       Date:  2014-04-06       Impact factor: 5.970

5.  Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity.

Authors:  Yanli Qin; Xiaoli Tang; Tamako Garcia; Munira Hussain; Jiming Zhang; Anna Lok; Jack Wands; Jisu Li; Shuping Tong
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

6.  Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration.

Authors:  P Gripon; C Diot; C Guguen-Guillouzo
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

7.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

8.  Role of glycosaminoglycans for binding and infection of hepatitis B virus.

Authors:  Corinna M Leistner; Stefanie Gruen-Bernhard; Dieter Glebe
Journal:  Cell Microbiol       Date:  2008-01       Impact factor: 3.715

Review 9.  Hepatitis B virus genetic variants: biological properties and clinical implications.

Authors:  Shuping Tong; Jisu Li; Jack R Wands; Yu-Mei Wen
Journal:  Emerg Microbes Infect       Date:  2013-03-13       Impact factor: 7.163

10.  Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).

Authors:  Koichi Watashi; Ann Sluder; Takuji Daito; Satoko Matsunaga; Akihide Ryo; Shushi Nagamori; Masashi Iwamoto; Syo Nakajima; Senko Tsukuda; Katyna Borroto-Esoda; Masaya Sugiyama; Yasuhito Tanaka; Yoshikatsu Kanai; Hiroyuki Kusuhara; Masashi Mizokami; Takaji Wakita
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

View more
  21 in total

1.  Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.

Authors:  Luhua Qiao; Jianhua Sui; Guangxiang Luo
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

2.  N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection In Vitro.

Authors:  Jiwon Lee; Li Zong; Alexander Krotow; Yanli Qin; Lucy Jia; Jiming Zhang; Shuping Tong; Jisu Li
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

3.  Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer.

Authors:  Huailiang Zhou; Dina Gewaily; Sang Hoon Ahn; Carina Preskill; Yongxiang Wang; Li Zong; Jing Zhang; Kwang-Hyub Han; Jack Wands; Jisu Li; Shuping Tong
Journal:  Virus Res       Date:  2017-04-01       Impact factor: 3.303

4.  Host cell-dependent late entry step as determinant of hepatitis B virus infection.

Authors:  Xupeng Hong; Yuka Imamura Kawasawa; Stephan Menne; Jianming Hu
Journal:  PLoS Pathog       Date:  2022-06-17       Impact factor: 7.464

5.  Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein.

Authors:  Xiaohui Bi; Shuping Tong
Journal:  Virology       Date:  2018-03-28       Impact factor: 3.616

6.  Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication.

Authors:  Shuwen Fu; Jing Zhang; Quan Yuan; Qianru Wang; Qiang Deng; Jisu Li; Ningshao Xia; Yongxiang Wang; Yumei Wen; Shuping Tong
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

7.  A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway.

Authors:  Jun-Fang Zhang; Hua-Long Xiong; Jia-Li Cao; Shao-Juan Wang; Xue-Ran Guo; Bi-Yun Lin; Ying Zhang; Jing-Hua Zhao; Ying-Bin Wang; Tian-Ying Zhang; Quan Yuan; Jun Zhang; Ning-Shao Xia
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

8.  Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus.

Authors:  Gansukh Choijilsuren; Ren-Shiang Jhou; Shu-Fan Chou; Ching-Jen Chang; Hwai-I Yang; Yang-Yuan Chen; Wan-Long Chuang; Ming-Lung Yu; Chiaho Shih
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

9.  Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses.

Authors:  Hironori Nishitsuji; Keisuke Harada; Saneyuki Ujino; Jing Zhang; Michinori Kohara; Masaya Sugiyama; Masashi Mizokami; Kunitada Shimotohno
Journal:  Cancer Sci       Date:  2017-12-07       Impact factor: 6.716

10.  The Envelope Gene of Hepatitis B Virus Is Implicated in Both Differential Virion Secretion and Genome Replication Capacities between Genotype B and Genotype C Isolates.

Authors:  Haodi Jia; Yanli Qin; Chaoyang Chen; Fei Zhang; Cheng Li; Li Zong; Yongxiang Wang; Jiming Zhang; Jisu Li; Yumei Wen; Shuping Tong
Journal:  Viruses       Date:  2017-03-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.